Fascinating hypothesis that immunosuppression may be harmful in patients with short telomeres and non-IPF ILD. Makes me think of our rapidly declining chronic HP patients #ICLAF2018

We are delighted to announce Repeat Diagnostics 🇨🇦 as one of our Lantern Level Sponsors! Thank you for supporting #TTSummit24. You can learn more about Repeat Dx by visiting repeatdx.com Join as a sponsor today: bit.ly/TTSummitSponsor

THANK YOU to everyone who has joined the PFF Community Registry so far! 🎉🎉 As a token of our gratitude, you can show your support of pulmonary fibrosis research with this profile picture. Haven’t enrolled yet? Get started at bit.ly/joinpffregistry.

🔥Patients with ILD experience delays in diagnosis. We interviewed patients and physicians to help understand why. We need to advocate for: - increased ILD awareness and education -access to chest imaging -earlier referral to respirology bmjopenrespres.bmj.com/content/bmjres… #curePF

Dr. Paul Wolters underscores the purpose of the diagnostic process. Identification of UIP is critical as it may be a singular unifier. However familial cases of PF may lack a UIP CT pattern. Telomere length is a common and very valuable biomarker that is helpful. #ATS2024

"Every 35 seconds, a life changes with a blood cancer diagnosis". On this #WorldBloodCancerDay, Repeat Diagnostics 🇨🇦 extends its support to those fighting lymphoma, leukemia, and more. Together, we can make a difference! 🧬🩸 bit.ly/3XZthwc

The Clinical Frailty Score is associated with risk of mortality and lung function decline in fibrotic ILD 👏Dr. Sabina Guler et al. @CARE-PF CHEST® Journal Link to free d/load here👇 authors.elsevier.com/c/1jBMe2p-lC~pg

@repeatdx stands in solidarity on #SickleCellDay, recognized by the UN and WHO. This day serves as a crucial reminder of the daily challenges faced by those with Sickle Cell Disease and the urgent need for action and support. 💪 🌍❤️ #SickleCellAwareness

In May board member Heidi attended ATS 2024. She presented a poster on accelerating diagnosis and treatment of pulmonary fibrosis in Telomere Biology Disorders. Hundreds stopped by to learn and download our guidelines: teamtelomere.org/diagnosis-mana… #telomeres #ATS2024 #TBDs

"If you are seeing #ILD patients, most likely you are seeing TBD patients due to the prevalence of short #telomere in ILD." Highlighted by Chad Newton in a brilliant presentation Pulmonary Fibrosis Foundation summit 2023👏.▶️More of the impact of TBDs on PF clinical care. bit.ly/3xIFy0s

Amazing collaboration!👏. Incredible work by the Telomere Associated Ailments Clinical Care Consortium and Team Telomere .More insights into the clinical characteristics, management, and outcomes of patients with TBD-related liver diseases.👉 bit.ly/3zmSfOX #Telomere

Thrilled to be part of the Team Telomere Scientific Summit 2024! 🌍🧬 Repeat Dx joins global experts to discuss advancements in telomere biology and improve patient care. Big thanks to Team Telomere for their dedication to the TBD community. #TTSummit24

Doug Simonetto, MD presenting data on Liver disease in patients with #Telomere biology disorders on behalf of the CCCTAA at #TTSummit24. Patients with TBD can have severe liver disease but can do well with Liver transplant. Batul Kaj-Carbaidwala

Excellent final talk of the #TTSummit24 from Christine Garcia Columbia University discussing the genetics of pulmonary fibrosis with an emphasis on #TBD. Team Telomere

Authors from the Interstitial Lung Disease (ILD) Section highlight the growing interest in telomere length and its response to immunosuppression in the ILD community: hubs.ly/Q02Hk2qK0